Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 143 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact143 DOIs

Deposit reference lists for 72 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact72 DOIs

Add abstracts to 66 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact66 DOIs

DOIs for this ISSN

Showing the top 5 of 550 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Precision Nutrition Initiative: Toward Personalized Diet Rec… (10.1093/crocol/otaa087)	Abstract ORCID	47.71	8
2	Patterns of Opioid Use Among Patients With Inflammatory Bowe… (10.1093/crocol/otaa010)	Abstract ORCID	45.15	7
3	Full, Partial, and Modified Permutations of the Mayo Score:… (10.1093/crocol/otab007)	ORCID	42.25	48
4	Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease… (10.1093/crocol/otaa003)	ORCID	40.32	40
5	The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients (10.1093/crocol/otaa026)	ORCID	36.18	27
6	Trends and Characteristics of Clinical Trials Participation… (10.1093/crocol/otaa023)	ORCID	35.37	25
7	Elevated Pretreatment Plasma Oncostatin M Is Associated With… (10.1093/crocol/otz026)	ORCID	35.37	25
8	Low Health Literacy Exists in the Inflammatory Bowel Disease… (10.1093/crocol/otaa076)	ORCID	33.56	21
9	Comparison of Real-World Treatment Outcomes With Vedolizumab… (10.1093/crocol/otz022)	ORCID	33.56	21
10	The Immunogenicity of the Influenza, Pneumococcal, and Hepat… (10.1093/crocol/otaa082)	ORCID	33.06	20
11	TELEmedicine for Patients With Inflammatory Bowel Disease (T… (10.1093/crocol/otaa002)	ORCID	32.53	19
12	Chronic Abdominal Pain in IBD Research Initiative: Unravelin… (10.1093/crocol/otab034)	Abstract	31.97	18
13	Opioid Use in Patients With Inflammatory Bowel Disease (10.1093/crocol/otaa009)	ORCID	29.40	14
14	A Single Center Experience With Long-Term Ustekinumab Use an… (10.1093/crocol/otaa013)	ORCID	29.40	14
15	Vaccination Rates and Family Barriers Among Children with In… (10.1093/crocol/otaa056)	ORCID	29.40	14
16	Low Skeletal Muscle Index Adjusted for Body Mass Index Is an… (10.1093/crocol/otaa064)	ORCID	28.65	13
17	The Efficacy and Safety of Switching From Originator Inflixi… (10.1093/crocol/otab022)	License	26.03	10
18	Impact of Diet on Risk of IBD (10.1093/crocol/otz054)	ORCID	26.03	10
19	Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Ant… (10.1093/crocol/otaa049)	ORCID	25.00	9
20	Switching from Infliximab to Biosimilar in Inflammatory Bowe… (10.1093/crocol/otaa093)	ORCID	25.00	9
21	Functional Molecular Network Analysis Enables Prediction of… (10.1093/crocol/otaa037)	ORCID	23.86	8
22	Bowel Preparation in Inflammatory Bowel Disease—A Necessary… (10.1093/crocol/otaa078)	Abstract ORCID	23.86	2
23	The Emotional Toll of Inflammatory Bowel Disease: Using Mach… (10.1093/crocol/otz011)	ORCID	23.86	8
24	The Use of An EHR Patient Portal (Mychart-Epic) in Patients… (10.1093/crocol/otz039)	ORCID	23.86	8
25	Patients’ Preference of Topical Therapy for Ulcerative Colit… (10.1093/crocol/otaa030)	ORCID	22.58	7
26	Gastroenterologist-Lead Management of Iron Deficiency Anemia… (10.1093/crocol/otaa051)	ORCID	22.58	7
27	Barriers to Psychosocial Support and Quality of Life for Pat… (10.1093/crocol/otaa068)	ORCID	22.58	7
28	Telenutrition for Inflammatory Bowel Disease: A Tipping Poin… (10.1093/crocol/otab017)	ORCID	22.58	7
29	Oral Vancomycin as an Adjuvant Treatment in IBD (10.1093/crocol/otz015)	ORCID	22.58	7
30	Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Hi… (10.1093/crocol/otz033)	ORCID	22.58	7
31	Caregiver and Adolescent Patient Perspectives on Comprehensi… (10.1093/crocol/otaa055)	ORCID	21.13	6
32	Extraintestinal Manifestations of Inflammatory Bowel Disease… (10.1093/crocol/otad058)	ORCID	21.13	6
33	Chronic Antibiotic Dependent Pouchitis Is Associated With Ol… (10.1093/crocol/otz029)	ORCID	21.13	6
34	Characteristics of Fecal Microbiota Transplantation Use in I… (10.1093/crocol/otaa024)	ORCID	19.45	5
35	Thiopurine exposure during pregnancy is not associated with… (10.1093/crocol/otad066)	References	19.45	5
36	Evidence of Disturbed Gut Microbial Metabolic Activity in Pe… (10.1093/crocol/otz010)	ORCID	19.45	5
37	The Early Experience With Vedolizumab in the United States (10.1093/crocol/otz027)	ORCID	19.45	5
38	Pericardial Manifestations in Inflammatory Bowel Disease: A… (10.1093/crocol/otz028)	ORCID	19.45	5
39	Listening to the Patient: Improving the Design and Conduct o… (10.1093/crocol/otaa011)	ORCID	17.47	4
40	Economic Outcomes of Inflammatory Bowel Disease Patients Swi… (10.1093/crocol/otaa031)	ORCID	17.47	4
41	Personalized Nutrition for Inflammatory Bowel Disease (10.1093/crocol/otaa042)	ORCID	17.47	4
42	Management of Asymptomatic Terminal Ileitis (10.1093/crocol/otaa065)	ORCID	17.47	4
43	Why Is There Low Utilization of Biosimilars in Inflammatory… (10.1093/crocol/otab004)	ORCID	17.47	4
44	Predicting 30-Day Readmission Rate in Inflammatory Bowel Dis… (10.1093/crocol/otz007)	ORCID	17.47	4
45	Changes in Patient-Reported Outcomes With Vedolizumab Therap… (10.1093/crocol/otz020)	ORCID	17.47	4
46	Biological Treatment and the Potential Risk of Adverse Posto… (10.1093/crocol/otz021)	ORCID	17.47	4
47	High Prevalence of Male Sexual Dysfunction in a Prospective… (10.1093/crocol/otaa004)	ORCID	15.05	3
48	Are We Able to Accurately Assess Post IPAA Pathology? (10.1093/crocol/otaa038)	Abstract ORCID	15.05	1
49	Changing Patterns of Relationships Between Geographic Marker… (10.1093/crocol/otaa044)	ORCID	15.05	3
50	Applying Endoscopic Interventions to Inflammatory Bowel Dise… (10.1093/crocol/otaa066)	Abstract ORCID	15.05	1